scispace - formally typeset
R

Robert A. Budinsky

Researcher at Dow Chemical Company

Publications -  62
Citations -  2387

Robert A. Budinsky is an academic researcher from Dow Chemical Company. The author has contributed to research in topics: Aryl hydrocarbon receptor & Population. The author has an hindex of 20, co-authored 59 publications receiving 2114 citations.

Papers
More filters
Journal ArticleDOI

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Patricio Godoy, +94 more
TL;DR: This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro and how closely hepatoma, stem cell and iPS cell–derived hepatocyte-like-cells resemble real hepatocytes.
Journal ArticleDOI

Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.

TL;DR: A scientific confidence framework for evaluating and applying a given AOP for different regulatory purposes ranging from prioritizing chemicals for further evaluation, to hazard prediction, and ultimately, risk assessment is proposed.
Journal ArticleDOI

Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

TL;DR: Evidence is provided for divergent cross-species gene expression changes in response to TCDD and is consistent with epidemiological and clinical evidence showing humans to be less sensitive to T CDD-induced hepatotoxicity.